Related Experiment Video
Updated: Mar 12, 2026

Expression, Isolation, and Purification of Soluble and Insoluble Biotinylated Proteins for Nerve Tissue Regeneration
Published on: January 22, 2014
PASylation technology improves recombinant interferon-β1b solubility, stability, and biological activity
Elizaveta A Zvonova1, Alexander V Ershov2, Olga A Ershova2
1International Biotechnology Center (IBC) "Generium", Vladimirskaya street 14, Volginsky village, Petushinsky district, Vladimir Region, 601125, Russia. berkovich@ibcgenerium.ru.
PASylation enhances recombinant interferon-β1b (IFN-β1b) for treating multiple sclerosis. This modification improves protein stability, solubility, and biological activity, potentially leading to better therapeutic properties.
Area of Science:
- Biotechnology
- Protein Engineering
- Pharmacology
Background:
- Recombinant interferon-β1b (IFN-β1b) is a therapeutic protein for multiple sclerosis.
- Its clinical application is limited by poor solubility, stability, and short in vivo half-life.
Purpose of the Study:
- To improve the therapeutic properties of IFN-β1b.
- To enhance its stability, solubility, and biological activity through PASylation.
Main Methods:
- Construction of two variants of IFN-β1b with a PAS sequence at either the C- or N-terminus.
- Evaluation of hydrodynamic volume, in vitro biological activity, stability, and solubility of modified proteins.
Main Results:
- PASylated IFN-β1b showed a 4-fold increase in hydrodynamic volume.
- In vitro biological activity increased 2-fold compared to unmodified IFN-β1b.
- Enhanced stability and solubility were observed in PAS-modified proteins.
Conclusions:
- PASylation significantly improves the stability, solubility, and functional activity of IFN-β1b.
- PASylation holds potential for enhancing the pharmacokinetic properties of IFN-β1b as a therapeutic agent.
Related Concept Videos
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Bioavailability Enhancement: Drug Permeability Enhancement
Drug Products: Biologics, Biosimilars and Interchangeables

